Clinical significance of Smac/DIABLO expression in colorectal cancer

Oncology Reports

Volumn 21, Issue 2, 2009, Pages 351-355

  Endo, Kazuya ^a,c   Kohnoe, Shunji ^b   Watanabe, Akihiro ^b   Tashiro, Hideya ^a   Sakata, Hisanobu ^a   Morita, Masaru ^c   Kakeji, Yoshihiro ^c   Maehara, Yoshihiko ^c  

^a OITA PREFECTURAL HOSPITAL   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

Colorectal cancer; Immunohistochemistry; Prognosis; Smac DIABLO

Indexed keywords

SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; DIABLO PROTEIN, HUMAN; MITOCHONDRIAL PROTEIN; SIGNAL PEPTIDE; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; ADENOCARCINOMA; BIOSYNTHESIS; COLORECTAL TUMOR; GENE EXPRESSION; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KAPLAN-MEIERS ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MITOCHONDRIAL PROTEINS; NEOPLASM STAGING; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 62849124148     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000229     Document Type: Article

References (40)

1. Galluzzi L, Larochette N, Zamzani N and Kroemer G: Mitochondria as therapeutic target for cancer chemotherapy. Oncogene 25: 4812-4830, 2006.
2. Bossy-Wetzel E and Green DR: Apoptosis: checkpoint at the mitomchondrial frontier. Mutat Res 434: 243-251, 1999.
3. Kromer G and Reed JC: Mitochondrial control of cell death. Nat Med 6: 513-519, 2000.
4. Kluck RM and Kashibatta S: A lively meeting of a deathly topic. Apoptosis 2: 337-342, 1997.
5. Yang J, Liu X, Balla K, Gillenwiter A, et al: Prevention of apoptosis by Bcl-2-Release of cytochrome-c from the mitochondria blocked. Science 275: 1129-1136, 1997.
6. Susin SA, Zamazami N, Castedo M, et al: Bcl-2 inhibits the mitochondrial release of an apoptogenic protease J Exp Med 184: 1331-1341, 1996.
7. Parrish L, Li K, Klotz D, et al: Mitochondrial endonuclease G is important for apoptosis in C. elegans. Nature 412: 90-94, 2001.
8. Hedge R, Srinivasula SM, Zhang Z, et al: Idetification of Omi/ HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction. J Biol Chem 277: 432-438, 2002.
9. Thornberry NA and Lazebnik Y: Caspases: enemies within. Science 281: 1312-1316, 1998.
10. Harada H and Grant S: Apoptosis regulators. Rev Clin Exp Hematol 7: 117-138, 2003.
11. Deveraux QL and Reed JC: IAP family proteins - suppressors of apoptosis. Genes Dev 13: 239-252, 1999.
12. Tamm I, Kornblau SM, Segall H, et al: Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. Clin Cancer Res 6: 1796-1803, 2000.
13. Krajewska M, Krajewski S, Banares S, et al: Elevated expression of inhibitor of apoptosis proteins in prostate cancer. Clin Cancer Res 9: 4914-4925, 2003.
14. Du C, Fang M, Li Y, Li L and Wang X: Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102: 33-42, 2000.
15. Verhagen AM, Ekert PG, Pakusch J, et al: Idetification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 102: 43-53, 2000.
16. Wu G, Chai J, Suber TL, et al: Structual basis of IAP recognition by Smac/DIABLO. Nature 408: 1008-1012, 2000.
17. Van Ginkel PR, Sareen D, Subramanian L, et al: Resveratrol inhibits tumor growth of human neuroblastoma and mediates apoptosis by directly targeting mitochondria. Clin Cancer Res 13: 5162-5169, 2007.
18. Weisberg E, Kung AL, Wright RD, et al: Potentiation of antileukemic therapies by Smac mimetics, LBW242: effects on mutant FLT3-expreaaing cells. Mol Cancer Ther 6: 1951-1961, 2007.
19. Sekimura A, Konishi A, Mizuno K, et al: Expression of Smac/DIABLO is a novel prognostic marker in lung cancer. Oncol Rep 11: 797-802, 2004.
20. Zheng LD, Tong QS, Wang L, Liu J and Qian W: Stable transfection of extrinsic Smac gene enhances apoptosis of chemotherapeutic drugs on gastric cancer cells. World J Gastroenterol 11: 79-83, 2005.
21. Bao ST, Gui SQ and Lin MS: Relationship between expression of Smac and Survivin and apoptosis of primary hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 5: 580-583, 2006.
22. Zhao J, Jin J, Zhang X, et al: Transfection of Smac sensitizes tumor cells to etoposide-induced apoptosis and eradicates ectablished human hepatoma in vivo. Cancer Gene Ther 13: 420-427, 2006.
23. Tirro E, Consoli ML, Massimino M, et al: Altered expression of c-IAP1, survivin and Smac contributes to chemotherapy resistance in thyroid cancer cells. Cancer Res 66: 4263-4272, 2006.
24. Mizutani Y, Nakanishi H, Yamamoto K, et al: Downregulation of Smac/DIABLO expression in renal cell carcinoma and its prognostic significance. J Clin Oncol 23: 448-454, 2005.
25. Rashmi R, Kumar S and Karunagaran D: Human colon cancer cells lacking Bax resist curcumin-induced apoptosis and Bax requirement is dispensable with ectopic expression of Smac or downregulation of Bcl-XL. Carcinogenesis 26: 713-723, 2005.
26. Sinicrope FA, Penington RC and Tang XM: Tumor necrosis factor-related apoptosis - inducing ligand-induced apoptosis is inhibited by Bcl-2 but restored by small molecule Bcl-2 inhibitor, HA 14-1, in human colon cancer cells. Clin Cancer Res 10: 8284-8292, 2004.
27. Kohli M, Yu J, Seaman C, et al: Smac/DIABLO-dependent apoptosis induced by nonsteroidal anti-inflammatory drugs(NSAIDs) in colon cancer cells. Proc Natl Acad Sci USA 101: 16897-16902, 2004.
28. Japanese Research Society of Cancer of the Colon and Rectum: General rules for clinical and pathologic studies on cancer of the colon, rectum and anus. Jpn J Surg 13: 557-573, 1983.
29. Ren Y, Akyurek N, Schlette E, Rassidakis GZ and Medetros LJ: Expression of Smac/DIABLO in B-cell non-Hodkin and Hodgkin lymphomas Hum Pathol 37: 1407-1413, 2006.
30. Cummins JM, Kohli M, Rago C, Kinzler KW, Vogelstein B and Bunz F: X-Linked Inhibitor of Apoptosis Protein(XIAP) is a nonredundant modulator of tumor necrosis factor-related apoptosis-inducing ligand(TRAIL)-mediated apoptosis in human cancer cells. Cancer Res 64: 3006-3008, 2004.
31. Sasaki H, Sheng Y, Kotsuji F, et al: Down regulation of X-linked inhibitor of apoptosis protein induces apoptosis in chemoresistant human ovarian cancer cells. Cancer Res 60: 5659-5666, 2000.
32. Zhang HG, Wang J, Yang X, Hsu HC and Mountz JD: Regulation of apoptosis proteins in cancer cells by ubiquitin. Oncogene 23: 2009-2015, 2004.
33. Goyal L: Cell death inhibition: Keeping caspases in check. Cell 104: 805-808, 2001.
34. Srinivasula SM, Hegde R, Saleh A, et al: A conserved XIAPinteraction motif in caspase-9 and Smac/DIABLO regulates caspase activity and apoptosis. Nature 410: 112-116, 2001.
35. Huerta S, Heinzerling JH, Anguiano-Hernandez YM, et al: Modification of gene products involved in resistance to apoptosis in metastatic colon cancer cells: Roles of Fas, Apaf-1, NFkB, IAPs, Smac/ DIABLO, and AIF. J Surg Res 142: 184-194, 2007.
36. Ogata Y, Torigoe S, Matono K, et al: Prognostic factors after potentially curative resection in stageII or III colon cancer. Kurume Med J 52: 67-71, 2005.
37. Anguiano-Hernandez YM, Chartier A and Huerta S: Smac/DIABLO and colon cancer. Anticancer Agents Med Chem 7: 467-473, 2007.
38. Gao Z, Tian Y, Wang J, et al: A dimeric Smac/Diablo peptide directly relieves caspase-3 inhibition by XIAP. Dynamic and cooperative regulation of XIAP by Smac/Diablo. J Biol Chem 282: 30718-30727, 2007.
39. Gaither A, Porter D, Yao Y, et al: A Smac mimetic rescue screen reveals roles for inhibitor of apoptsis protein in tumor necrosis factor-a signaling. Cancer Res 67: 11493-11498, 2007.
40. Bank A, Wang P, Du C, Yu J and Zhang L: Smac mimetics sensitize nonsteroidal anti-inflammatory drug induced apoptosis by promoting caspase-3 mediated cytochrome c release. Cancer Res 68: 276-284, 2008.